Editorial notice: TotalCareMedical.com is an independent health and wellness research publication. This comparison is for educational and informational purposes only and does not constitute medical advice or a recommendation for any specific program. GLP-1 medications are prescription drugs. Compounded medications discussed here have not been reviewed or approved by the FDA for safety, effectiveness, or quality. All pricing and program details are based on publicly available information at the time of publication and are subject to change — verify directly with each platform before enrolling. Some links on this page may be affiliate links; see our disclosure for details.
Comparing GLP-1 Telehealth Programs: What Actually Matters
The compounded GLP-1 telehealth market has expanded significantly heading into 2026, and the number of platforms offering virtual GLP-1 programs has made program comparison increasingly relevant for patients doing due diligence before enrolling. This comparison evaluates Wellorithm against other programs reviewed on this site — TeleHealth Med and SynergyRx GLP-1 Weight Loss — on the dimensions that most affect the patient experience: pricing structure, medication options, pharmacy sourcing, refund policy, clinical intake, and what each program includes.
For the full independent review of Wellorithm's program terms and structure, see our Wellorithm review. For the full index of telehealth platform reviews on this site, visit the telehealth platform reviews hub.
The Comparison Framework
Before comparing platforms, it is worth establishing what the comparison is and is not. This is a comparison of published program terms and structures — not a clinical efficacy comparison. The GLP-1 medications (semaglutide and tirzepatide) are the same active ingredients across all compounded programs. Clinical outcomes depend on the medication class itself, the dose prescribed and titrated, patient adherence, and lifestyle factors — not on which telehealth platform facilitated the prescription. Choosing the right platform is about access, cost structure, clinical process quality, and consumer protection terms — not about the medication performing differently based on where you enrolled.
Wellorithm: Program Summary
Wellorithm is a telehealth platform connecting patients with licensed clinicians for compounded GLP-1 evaluation. The program offers compounded semaglutide (injection and oral dissolving tablets) and compounded tirzepatide (injection and oral dissolving tablets). All medications are compounded formulations — not FDA-approved brand-name products. According to the official website, published starting prices are $147 for compounded semaglutide and $249 for compounded tirzepatide. Membership is billed on a 28-day recurring cycle. Payments are non-refundable once processed; cancellation is available at any time by contacting support via email. The platform serves 49 states (Louisiana excluded). Support is available 24/7 at +1 (877) 402-6778. The program operates on a cash-pay basis — insurance is generally not billed directly.
TeleHealth Med: Program Summary
TeleHealth Med is a compounded GLP-1 telehealth program that connects patients with licensed providers for online consultation, prescription, and home medication delivery through licensed U.S. pharmacies. The program's published starting price is $147. Its model follows the same three-entity structure as Wellorithm: platform, independent licensed clinicians, and pharmacy partners. The program is described as offering personalized treatment plans, 24/7 support, and flexible video consultation scheduling. As with Wellorithm, compounded medications offered through TeleHealth Med have not been reviewed or approved by the FDA for safety, effectiveness, or quality.
SynergyRx GLP-1 Weight Loss: Program Summary
SynergyRx GLP-1 Weight Loss distinguishes itself from Wellorithm and TeleHealth Med primarily by offering both compounded GLP-1 options and FDA-approved brand-name medications — Wegovy, Ozempic, and Mounjaro — for patients for whom brand-name products are clinically appropriate. Published starting prices for SynergyRx are higher across the compounded tier: compounded semaglutide injection from $199, compounded tirzepatide injection from $349, oral compounded semaglutide from $299, oral compounded tirzepatide from $399. Brand-name options start at $499 (Ozempic) or $947 (Wegovy, Mounjaro). The program names its medical team (Lion MD, led by Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD) and pharmacy partners (Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx), providing a level of sourcing transparency that patients evaluating compounded medication programs may find relevant. The program is available in all 50 states per its published FAQ.
Head-to-Head: Key Comparison Dimensions
Pricing for compounded semaglutide: Wellorithm from $147, TeleHealth Med from $147, SynergyRx from $199. All are starting prices subject to dose and plan. Wellorithm and TeleHealth Med are at price parity on the published entry price for this medication.
Pricing for compounded tirzepatide: Wellorithm from $249, SynergyRx from $349. TeleHealth Med's tirzepatide pricing was not separately published in available materials at the time of this review — verify directly with the platform.
Medication scope: Wellorithm and TeleHealth Med offer compounded formulations only. SynergyRx offers both compounded and FDA-approved brand-name options, making it the only platform of the three with a pathway to Wegovy, Ozempic, or Mounjaro for patients who qualify and for whom the cost is accessible.
Pharmacy sourcing transparency: SynergyRx names its pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx). Wellorithm refers to “trusted U.S. pharmacies” without naming partners in publicly available materials. TeleHealth Med similarly references licensed U.S. pharmacy partners. For patients who want to independently verify the compounding compliance status of the dispensing pharmacy, named partners provide a research pathway that unnamed references do not.
Refund terms: Wellorithm's published terms state payments are non-refundable once processed. SynergyRx and TeleHealth Med refund policies should be verified directly with each platform — terms vary across the category and are subject to change.
State coverage: Wellorithm serves 49 states (Louisiana excluded). SynergyRx is published as available in all 50 states. Verify your state's current availability with each platform before enrolling.
Clinical intake depth: All three programs require a digital health questionnaire and clinician evaluation before prescribing. SynergyRx's published clinical description is the most detailed of the three — it specifies eligibility criteria (BMI ≥30 or ≥27 with comorbidity), names the medical team, and details the titration approach. Wellorithm's published intake description (2-minute quiz) is less detailed about clinical evaluation depth — this is worth confirming directly with the platform for patients who want to understand the thoroughness of the screening process.
How to Choose: Questions Worth Asking
The right program is the one that fits your health profile, budget, state, and preferences for medication type and clinical process depth. These are the questions worth asking before enrolling in any of these programs.
Do you want access to FDA-approved brand-name medications if compounded options become unavailable or if your clinician recommends them? If yes, SynergyRx is the only platform of the three with that pathway published. Is price the primary constraint? Wellorithm and TeleHealth Med offer the lowest published starting prices in this comparison. Do you want to know which pharmacy will dispense your medication so you can independently verify its compounding compliance status? SynergyRx provides named pharmacy partners. Is state availability a factor — are you in Louisiana? Only SynergyRx publishes 50-state availability among the three platforms reviewed here. What is the refund policy if you are not approved for a prescription or decide not to proceed after enrollment? This should be confirmed in writing before providing payment information to any platform.
Frequently Asked Questions
How does Wellorithm compare to other GLP-1 telehealth programs on price? Wellorithm's published starting prices — $147 for compounded semaglutide, $249 for compounded tirzepatide — are at the lower end of published pricing in the compounded GLP-1 telehealth category. Actual costs depend on dosage and plan. Comparable platforms in this category publish semaglutide starting prices ranging from $147 to $350 or higher, with tirzepatide priced above semaglutide across the category. Price comparisons should account for what is included: consultation fees, monitoring, and pharmacy sourcing vary by platform.
What makes Wellorithm different from SynergyRx? SynergyRx offers both compounded and FDA-approved brand-name GLP-1 options, including Wegovy, Ozempic, and Mounjaro, with named pharmacy partners and a named medical team. Wellorithm focuses on compounded formulations only, at lower published starting prices, with 24/7 support access. Both are cash-pay programs. The right choice depends on whether brand-name medication access matters to you and what total cost structure fits your situation.
Which GLP-1 telehealth platform is best? No single platform is universally best. The right program depends on individual health profile, budget, medication preference (compounded vs. brand-name), state availability, and the clinical intake process. The most important evaluation dimensions are: whether the clinician evaluation is thorough, what pharmacy dispenses the medication and what its compounding compliance status is, what follow-up monitoring is included, and what the refund and cancellation terms are.